. "B6. Uses of Antiprogestins After 63 Days of Amenorrhea." Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press, 1993.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda
between prostaglandin administration and expulsion in second trimester abortion. British Journal of Obstetrics and Gynaecology 97:41–45, 1990.
Stiemer, B., and Elger, W. Cervical ripening of the rat in dependence of endocrine milieu: Effects of antigestagens. Journal of Perinatal Medicine (Berlin) 18:419–429, 1990.
Thong, K.J., and Baird, D.T. A study of gemeprost alone, Dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy. Contraception 46:11–17, 1992.
Ulmann, A., Teutsch, G., and Philibert, D. RU 486. Scientific American 262:42–48, 1990.
Urquhart, D.R., Bahzad, C., and Templeton, A.A. Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination in pregnancy. Human Reproduction 4:202–203, 1989.
Wolf, J.P., Sinosich, M., Anderson, T.L., et al. Progesterone antagonist (RU 486) for cervical dilation, labor induction and delivery in monkeys: Effectiveness in combination with oxytocin. American Journal of Obstetrics and Gynecology 160:45–47, 1989.
World Health Organization (WHO). The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. British Journal of Obstetrics and Gynaecology 97:260–266, 1990.